within Pharmacolibrary.Drugs.ATC.S;

model S01XA18
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.01,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 0.001,
    adminCount     = 1,
    Vd             = 0,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Ciclosporin (also known as cyclosporine) is a calcineurin inhibitor immunosuppressant used to prevent organ transplant rejection, and to treat certain autoimmune diseases. It is clinically approved and in use today, including topical ophthalmic formulations (ATC S01XA18) for conditions such as dry eye disease.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in adults after ophthalmic (eye drop) administration; limited systemic absorption expected.</p><h4>References</h4><ol><li><p>Tang-Liu, DD, &amp; Acheampong, A (2005). Ocular pharmacokinetics and safety of ciclosporin, a novel topical treatment for dry eye. <i>Clinical pharmacokinetics</i> 44(3) 247–261. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200544030-00003&quot;>10.2165/00003088-200544030-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15762768/&quot;>https://pubmed.ncbi.nlm.nih.gov/15762768</a></p></li><li><p>Bos, JD, &amp; Meinardi, MM (2000). The 500 Dalton rule for the skin penetration of chemical compounds and drugs. <i>Experimental dermatology</i> 9(3) 165–169. DOI:<a href=&quot;https://doi.org/10.1034/j.1600-0625.2000.009003165.x&quot;>10.1034/j.1600-0625.2000.009003165.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10839713/&quot;>https://pubmed.ncbi.nlm.nih.gov/10839713</a></p></li><li><p>Mandal, A, et al., &amp; Mitra, AK (2019). Ocular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa®) for Dry Eye Disease. <i>Pharmaceutical research</i> 36(2) 36–None. DOI:<a href=&quot;https://doi.org/10.1007/s11095-018-2556-5&quot;>10.1007/s11095-018-2556-5</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30617777/&quot;>https://pubmed.ncbi.nlm.nih.gov/30617777</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end S01XA18;
